55648 Federal Register / Vol. 62, No. 207 / Monday, October 27, 1997 / Notices

and Nutrition and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health)

Dated: October 21, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–28374 Filed 10–24–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Diabetes and

Digestive and Kidney Diseases Special

Emphasis Panel meeting:

Name of SEP: ZDK1–GRB–7 (J1).

Date: November 17–19, 1997.

Time: 7:30 PM.

Place: The Quarterage Hotel, 560 Westport

Road, Kansas City, MO 64111.

Contact Person: Lakshmanan Sankaran,

Ph.D., Scientific Review Administrator,

Review Branch, DEA, NIDDK, Natcher

Building, Room 6as–25F, National Institutes

of Health, Bethesda, Maryland 20892–6600,

Phone: (301) 594–7799.

Purpose/Agenda: To review and evaluate

grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health)

Dated: October 21, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–28375 Filed 10–24–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Diabetes and

Digestive and Kidney Diseases Special

Emphasis Panel meeting:

Name of SEP: ZDK1–GRB–8 (J1).

Date: November 21, 1997.

Time: 2:00 pm.

Place: Room 6as–25N, Natcher Building,

NIH (Telephone Conference Call).

Contact Person: Roberta Haber, Ph.D.,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Natcher Building,

Room 6as–25N, National Institutes of Health,

Bethesda, Maryland 20892–6600, Phone:

(301) 594–8898.

Purpose/Agenda: To review and evaluate

grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

associations and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health)

Dated: October 21, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–28376 Filed 10–24–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Child Health and

Human Development Special Emphasis

Panel (SEP) meeting:

Name of SEP: Rehabilitation Research

Training Grants (TELECONFERENCE).

Date: November 17, 1997.

Time: 1:00 p.m. (ET)—adjournment.

Place: Division of Scientific Review, 6100

Executive Boulevard, Room 5E01, Rockville,

Maryland 20852.

Contact Person: Hameed Khan, Ph.D.,

Scientific Review Administrator, NICHD,

6100 Executive Boulevard, 6100 Building—

Room 5E01, Rockville, Maryland 20852,

Telephone: 301–496–1485.

Purpose/Agenda: To evaluate and review

research grant applications.

This meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

discussion of these applications could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the applications, the

disclosure of which would constitute a

clearly unwarranted invasion of personal

privacy.

(Catalog of Federal Domestic Assistance

Program Nos. [93.864, Population Research

and No. 93.865, Research for Mothers and

Children], National Institutes of Health, HHS)

Dated: October 21, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–28377 Filed 10–24–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Prospective Grant of Exclusive

License: Synthetic, Anti-Complement

Protein and Gene Useful in Transplant

Therapeutics

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: This notice is in accordance

with 35 U.S.C. 209(c)(1) and 37 CFR

404.7 (a)(1)(i) that the National

Institutes of Health (NIH), Department

of Health and Human Services, is

contemplating the grant of an exclusive

and world-wide license to practice the

invention embodied in U.S. Patent

Application Serial No. 07/906,983 (U.S.

Patent No. 5,187,268, issued February

16, 1993) entitled ‘‘Gene Encoding an

Anti-Complement Protein From

Vaccinia’’ and U.S. Patent Application

Serial No. 07/239,208 (U.S. Patent No.

5,157,110, issued October 20, 1992)

entitled ‘‘Synthetic, Anti-Complement

Protein’’ to Johns Hopkins University of

Baltimore, Maryland. The patent rights

in these inventions have been assigned

to the United States of America.

It is anticipated that this license may

be limited to the field of transplant

therapeutics.

DATES: Only written comments and/or

applications for a license which are